SCHEMBL8097091

SCHEMBL8097091

CCC(CF)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.48
CCR5 P51681 1/20 0.44
TAAR1 Q96RJ0 5/20 0.40
CYP2D6 P10635 1/20 0.40
MIF P14174 1/20 0.39
HKDC1 Q2TB90 1/20 0.38
TRPA1 O75762 1/20 0.38
HTR2A P28223 2/20 0.38
HRH1 P35367 1/20 0.38
AOC3 Q16853 1/20 0.37
NOS3 P29474 1/20 0.37
NOS2 P35228 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
GABBR2 O75899 1/20 0.36
GABBR1 Q9UBS5 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1415533 0.85 TAAR1 (0.43) LMNATAAR1CYP2D6HTR2AHRH1
SCHEMBL169508 0.85 LMNA (0.56) LMNACCR5TAAR1CYP2D6MIF
Ammonia Solution, Strong SCHEMBL1640901 0.82 LMNA (0.54) LMNACCR5TAAR1CYP2D6MIF
SCHEMBL8090799 0.82 AOC3 (0.43) LMNACCR5TAAR1HTR2AHRH1
SCHEMBL2240978 0.81 LMNA (0.48) LMNACCR5TAAR1CYP2D6MIF
SCHEMBL7775432 0.81 LMNA (0.48) LMNACCR5TAAR1CYP2D6MIF
SCHEMBL5890038 0.81 LMNA (0.48) LMNACCR5TAAR1CYP2D6MIF
SCHEMBL12341793 0.80 HTR2A (0.40) LMNATAAR1CYP2D6HTR2AHRH1
Methylamine SCHEMBL27931105 0.80 LMNA (0.52) LMNACCR5TAAR1CYP2D6HTR2A
Hypochlorous Acid SCHEMBL11415854 0.78 LMNA (0.56) LMNACCR5TAAR1CYP2D6HKDC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3632910-B1 3,4-DIHYDROQUINOLINONES AS FXR RECEPTOR AGONISTS CSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD (CN) 2024-07-17 EP disclosed
US-9339592-B2 Polymers of fluorinated monomers and hydrocarbon monomers ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) 2016-05-17 US disclosed
US-9289535-B2 Polymers of fluorinated monomers and hydrocarbon monomers ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) 2016-03-22 US disclosed
US-9220816-B2 Polymers of fluorinated monomers and hydrocarbon monomers ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) 2015-12-29 US disclosed
US-8529932-B2 Polymers of fluorinated monomers and hydrocarbon monomers ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2013-09-10 US disclosed
US-8529930-B2 Polymers of fluorinated monomers and hydrocarbon monomers ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2013-09-10 US disclosed
US-8529931-B2 Polymers of fluorinated monomers and hydrocarbon monomers ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2013-09-10 US disclosed
US-8524266-B2 Polymers of fluorinated monomers and hydrocarbon monomers ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2013-09-03 US disclosed
US-20100016533-A1 POLYMERS OF FLUORINATED MONOMERS AND HYDROCARBON MONOMERS ADVANCED CARDIOVASCULAR SYSTEMS, INC. 2010-01-21 US disclosed
US-20100003303-A1 POLYMERS OF FLUORINATED MONOMERS AND HYDROCARBON MONOMERS ADVANCED CARDIOVASCULAR SYSTEMS, INC. 2010-01-07 US disclosed
US-20100004396-A1 POLYMERS OF FLUORINATED MONOMERS AND HYDROCARBON MONOMERS ADVANCED CARDIOVASCULAR SYSTEMS, INC. 2010-01-07 US disclosed
US-20100003231-A1 POLYMERS OF FLUORINATED MONOMERS AND HYDROCARBON MONOMERS ADVANCED CARDIOVASCULAR SYSTEMS, INC. 2010-01-07 US disclosed
US-7604818-B2 Polymers of fluorinated monomers and hydrocarbon monomers ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2009-10-20 US disclosed
US-20070191561-A1 Polymers of fluorinated monomers and hydrocarbon monomers ADVANCED CARDIOVASCULAR SYSTEMS, INC. 2007-08-16 US disclosed
EP-1053990-A2 A method of producing an aromatic ketone and an aromatic ketone composition containing it TORAY INDUSTRIES, INC. (JP) 2000-11-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100003231-A1 POLYMERS OF FLUORINATED MONOMERS AND HYDROCARBON MONOMERS AHR, FPR1, HMBS LMNA 3139/4885CCR5 918/4885TAAR1 617/4885
US-20100003303-A1 POLYMERS OF FLUORINATED MONOMERS AND HYDROCARBON MONOMERS HMBS, PAH, AHR LMNA 2278/4885CCR5 1113/4885TAAR1 714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.